PulseSight Therapeutics
PrivateLast Round
Series A
Feb 13, 2025
Total Funding Raised
$54.14M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
PulseSight Therapeutics is a biotechnology company that develops non-viral gene therapies for the treatment of retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PulseSight Therapeutics Comparables
Compare PulseSight Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Complement Therapeutics | 82% | |
| Atsena Therapeutics | 79% | |
| Eli Lilly and Company | 78% |
PulseSight Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 13, 2025 | ||||
| Seed | Feb 28, 2024 | ||||
| Series B Extension | Aug 4, 2021 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Sep 16, 2016 | ||||
VC Round | Apr 11, 2013 |
Key People
Founding team and executive leadership
PulseSight Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Seed, Series B Extension |
| Inserm Transfert | Series A, Seed, Series B, VC Round |
| Pontifax Venture Capital | Series A, Series B |
| +ND Capital | Seed |
| Pureos Bioventures | Series A, Series B, Seed |
| Boehringer Ingelheim Venture Fund | Series A, VC Round, Series B |
| Karista | Series A, Seed, Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- Jul 26, 2026
Monthly visitors increased 43% MoM.
PulseSight Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PulseSight Therapeutics's valuation, stock price, and market status.
Is PulseSight Therapeutics a public or private company?
PulseSight Therapeutics is a private company.
What is the current stock price of PulseSight Therapeutics?
PulseSight Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is PulseSight Therapeutics worth (valuation)?
Valuation information for PulseSight Therapeutics is not publicly available.
Can I buy PulseSight Therapeutics stock?
PulseSight Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PulseSight Therapeutics's last funding round?
PulseSight Therapeutics's most recent funding round was Series A on February 14, 2025.
Who are the main investors in PulseSight Therapeutics?
Key investors in PulseSight Therapeutics include Pureos Bioventures, ND Capital.
Will PulseSight Therapeutics IPO soon?
No public IPO plans have been announced for PulseSight Therapeutics.
How can I track PulseSight Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PulseSight Therapeutics's secondary market activity and sign up for updates.